BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3366172)

  • 1. Bimodal effect of oxytocin on avoidance behavior may be caused by the presence of two peptide sequences with opposite action in the same molecule.
    Gaffori OJ; De Wied D
    Eur J Pharmacol; 1988 Mar; 147(2):157-62. PubMed ID: 3366172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure activity relationship studies with C-terminal fragments of vasopressin and oxytocin on avoidance behaviors of rats.
    de Wied D; Gaffori O; Burbach JP; Kovács GL; van Ree JM
    J Pharmacol Exp Ther; 1987 Apr; 241(1):268-74. PubMed ID: 3572787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of amphetamine and haloperidol on avoidance behavior and exploratory activity.
    Kovács GL; de Wied D
    Eur J Pharmacol; 1978 Dec; 53(1):103-7. PubMed ID: 738353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioral and electrophysiological effects of peptides related to lipotropin (beta-LPH).
    de Wied D; Bohus B; van Ree JM; Urban I
    J Pharmacol Exp Ther; 1978 Mar; 204(3):570-80. PubMed ID: 204766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central administration of oxytocin receptor ligands affects cued fear extinction in rats and mice in a timepoint-dependent manner.
    Toth I; Neumann ID; Slattery DA
    Psychopharmacology (Berl); 2012 Sep; 223(2):149-58. PubMed ID: 22526533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactive effects of neurohypophyseal neuropeptides with receptor antagonists on passive avoidance behavior: mediation by a cerebral neurohypophyseal hormone receptor?
    de Wied D; Elands J; Kovács G
    Proc Natl Acad Sci U S A; 1991 Feb; 88(4):1494-8. PubMed ID: 1847526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of amylin on motivated behavior in rats.
    Kovács AM; Telegdy G
    Physiol Behav; 1996 Jul; 60(1):183-6. PubMed ID: 8804661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of ACTH4-10, DG-AVP, and DG-OXT on heart rate and passive avoidance behavior in rats.
    Wan R; Diamant M; de Jong W; de Wied D
    Physiol Behav; 1992 Mar; 51(3):507-13. PubMed ID: 1326112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Further evidence for a dissociation of peripheral and central effects of vasopressin.
    Gaffori O; de Wied D
    Psychoneuroendocrinology; 1985; 10(4):439-44. PubMed ID: 4089084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of oxytocin and vasopressin on memory consolidation: sites of action and catecholaminergic correlates after local microinjection into limbic-midbrain structures.
    Kovács GL; Bohus B; Versteeg DH; de Kloet ER; de Wied D
    Brain Res; 1979 Oct; 175(2):303-14. PubMed ID: 487159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The interaction between beta-[Tyr9]melanotropin-(9-18), haloperidol and amphetamine in different behavior tests of rats.
    Telegdy G; Vécsei L; Schally AV; Coy DH
    Pharmacol Biochem Behav; 1982 Jul; 17(1):15-8. PubMed ID: 7122660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential behavioral effects of ACTH 4-10 and [D-Phe7] ACTH 4-10.
    Wiegant VM; Colbern D; van Wimersma Greidanus TJ; Gispen WH
    Brain Res Bull; 1978; 3(2):167-70. PubMed ID: 206319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-related effects of CRF and CRF-derived peptides: dissociation of behavioral, endocrine and autonomic activity.
    Diamant M; de Wied D
    Neuroendocrinology; 1993 Jun; 57(6):1071-81. PubMed ID: 8232765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Naltrexone-insensitive facilitation and naltrexone-sensitive inhibition of passive avoidance behavior of the ACTH-(4-9) analog (ORG 2766) are located in two different parts of the molecule.
    Fekete M; De Wied D
    Eur J Pharmacol; 1982 Jul; 81(3):441-8. PubMed ID: 6288413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vasopressin analogs: sedative properties and passive avoidance behavior in rats.
    Krejcí I; Kupková B; Metys J; Barth T; Jost K
    Eur J Pharmacol; 1979 Jul; 56(4):347-53. PubMed ID: 477729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potency and duration of action of the ACTH 4-9 analog (ORG 2766) as compared to ACTH 4-10 and [D-Phe7] ACTH 4-10 on active and passive avoidance behavior of rats.
    Fekete M; De Wied D
    Pharmacol Biochem Behav; 1982 Mar; 16(3):387-92. PubMed ID: 6281814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of des-Tyr1-gamma-endorphin and des-enkephalin-gamma-endorphin on active and passive avoidance behavior of rats; a dose-response relationship study.
    Gaffori O; De Wied D
    Eur J Pharmacol; 1982 Nov; 85(1):115-9. PubMed ID: 7151858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of physiological doses of vasopressin and oxytocin on avoidance and exploratory behaviour in rats.
    Schultz H; Kovács GL; Telegdy G
    Acta Physiol Acad Sci Hung; 1974; 45(3-4):211-5. PubMed ID: 4471267
    [No Abstract]   [Full Text] [Related]  

  • 19. Oxytocin selectively increases holding and licking of neonates in preweanling but not postweanling juvenile rats.
    Peterson G; Mason GA; Barakat AS; Pedersen CA
    Behav Neurosci; 1991 Jun; 105(3):470-7. PubMed ID: 1863367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Passive avoidance behavior: opposite effects of oxytocin analogs with agonist and antagonist properties.
    Krejcí I; Kupková B; Dlabac A
    Regul Pept; 1981 Sep; 2(5):285-91. PubMed ID: 7302291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.